Juvenile dermatomyositis: a review

Malleson, Peter
January 1982
Journal of the Royal Society of Medicine;Jan1982, Vol. 75 Issue 1, p33
Academic Journal
The article offers information on the clinical features of juvenile dermatomyositis (JDMS) and its treatment. The mean age of onset of JDMS is about 7 years, ranging from the first year of life upwards, and girls are affected twice as frequently as boys. It is a chronic inflammatory disease affecting muscle and skin but also often involving the gastrointestinal tract. JDMS is responsive to treatment and, if diagnosed early and treated vigorously, the great majority of affected children can be expected to make a good recovery.


Related Articles

  • High-Dose Intravenous Immunoglobulins in Dermatomyositis. Ulmer, Anja; Schanz, Stefan; Fierlbeck, Gerhard // Current Medical Literature: Dermatology;2013, Vol. 18 Issue 3, p53 

    The article presents information on the therapeutic use of high-dose intravenous immunoglobulins (Igs) in dermatomyositis. Dermatomyositis falls in the category of idiopathic inflammatory myopathies, that are muscle diseases. Dematomyositis can be easily recognized in case the patient suffers...

  • Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis. Smoyer-Tomic, Karen E.; Amato, Anthony A.; Fernandes, Ancilla W. // BMC Musculoskeletal Disorders;2012, Vol. 13 Issue 1, p103 

    Background: Idiopathic inflammatory myopathies (IIMs) are a rare group of autoimmune syndromes characterized by chronic muscle inflammation and muscle weakness with no known cause. Little is known about their incidence and prevalence. This study reports the incidence and prevalence of IIMs among...

  • Dermatomyositis. Koler, Ric Anthony; Montemarano, Andrew // American Family Physician;11/1/2001, Vol. 64 Issue 9, p1565 

    Dermatomyositis is an idiopathic inflammatory myopathy with characteristic skin manifestations. Although the disorder is rare, with a prevalence of one to10 cases per million in adults and one to 3.2 cases per million in children, early recognition and treatment are important ways to decrease...

  • Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study. Phillips, Beverley A.; Zilko, Paul J.; Garlepp, Michael J.; Mastaglia, Frank L. // Journal of Neurology;Apr2002, Vol. 249 Issue 4, p441 

    The seasonal occurrence of relapses was analysed retrospectively in a group of 53 patients with treated dermatomyositis (DM) or polymyositis (PM). In DM, the incidence of both myositic and cutaneous relapses was highest in summer whereas in the PM group relapses was more evenly distributed...

  • Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up. Ng, K. P.; Ramos, F.; Sultan, S. M.; Isenberg, D. A. // Clinical Rheumatology;Aug2009, Vol. 28 Issue 8, p947 

    This study aims to report the concomitant diseases observed and damage outcome in a cohort of patients with adult idiopathic inflammatory myositis (IIM) during long-term follow-up. All patients with IIM were identified from a single centre (follow-up between 1979 and 2006) and fulfilled at least...

  • Spontaneous recovery of dermatomyositis and unspecified myositis in three adult patients. van de Vlekkert, J.; Hoogendijk, J. E.; Frijns, C. J. M.; de Visser, M. // Journal of Neurology, Neurosurgery & Psychiatry;Jun2008, Vol. 79 Issue 6, p729 

    Dermatomyositis (DM), polymyositis and unspecified myositis are idiopathic inflammatory myopathies in which prednisone is usually started as soon as the diagnosis has been established. Therefore, little is known about the natural history of these diseases and spontaneous recovery may escape...

  • Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis? Schleinitz, Nicolas; Jean, Estelle; Benarous, Lucas; Mazodier, Karin; Figarella-Branger, Dominique; Bernit, Emmanuelle; Veit, VĂ©ronique; Kaplanski, Gilles; Harle, Jean-Robert // Clinical Rheumatology;Aug2008, Vol. 27 Issue 8, p1067 

    Monthly high-dose intravenous administration of human polyclonal immunoglobulins (IVIG) has been shown to be effective as an adjuvant treatment for dermatomyositis. We report a patient with dermatomyositis treated with high doses of immunoglobulins by subcutaneous infusion (SCIG). SCIG was used...

  • Pathophysiological Factors which Determine the Exercise Intolerance in Patients with Juvenile Dermatomyositis. Takken, Tim; Elst, Elisabeth F.; Van der Net, Janjaap // Current Rheumatology Reviews;2005, Vol. 1 Issue 1, p91 

    Juvenile Dermatomyositis (JDM) is one of the idiopathic inflammatory myopathies in childhood. In this disease the immune system targets the microvasculature of the skeletal muscle and skin, leading to myopathy and a typical skin rash. During episodes of active disease patients experience a...

  • Interstitial Lung Disease in Idiopathic Inflammatory Myopathy. Saketkoo, Lesley Ann; Ascherman, Dana P.; Cottin, Vincent; Christopher-Stine, Lisa; Danoff, Sonye K.; Oddis, Chester V. // Current Rheumatology Reviews;2010, Vol. 6 Issue 2, p108 

    The lung is one of the most common extra-muscular targets in idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) is a prevalent and often devastating manifestation of IIM. IIM-associated ILD (IIM-ILD) contributes to nearly 80% of the mortality in IIM with a reported...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics